Long-term follow-up of individuals with Chagas disease treated with posaconazole and benznidazole in a non-endemic region: the CHAGASAZOL cohort
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
- Publicado em
- 27 mar 2025
- Citações
- 8
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Long-term follow-up of individuals with Chagas disease treated with posaconazole and benznidazole in a non-endemic region: the CHAGASAZOL cohort
Joan Roig-Sanchis, Pau Bosch-Nicolau, Aroa Silgado, Fernando Salvador, Adrián Sánchez-Montalvá, Marisa Aznar, Inés Oliveira, Juan Espinosa-Pereiro, Núria Serre-Delcor, Diana Pou et al.
Descritores MeSH
- Trypanocidal Agents
- Nitroimidazoles
- Chagas Disease
- Triazoles
- Humans
- Male
- Middle Aged
- Prospective Studies
- Trypanosoma cruzi
- Adult
Veja também
Estudos relacionados
- Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA)
- Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials
- Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease
- Trypanosoma cruzi DTU diversity, benznidazole response, and clinical manifestations of Chagas disease: a seventeen-year systematic review and meta-analysis